Skip to main content
. 2023 Feb 16;25(4):1441–1450. doi: 10.1093/europace/euad025

Table 2.

Clinical outcomes of right ventricular pacing burden more than 30% 1 year after post-TAVR pacemaker implantation

RVPB <30% (n = 36) RVPB ≥30% (n = 74) Unadjusted HR (95% CI) P-value Adjusted HR (95% CI) P-value
All-cause mortality 8 (22.2%) 23 (31.1%) 1.687 (0.754–3.777) 0.203 2.122 (0.777–5.799) 0.142
Cardiac mortality 2 (5.6%) 8 (10.8%) 2.296 (0.487–10.827) 0.293 4.361 (0.509–37.341) 0.179
HF readmission 3 (8.3%) 22 (29.7%) 4.615 (1.375–15.494) 0.013 6.333 (1.417–28.311) 0.016
Composite (all-cause mortality and/or HF) 10 (27.8%) 31 (41.9%) 2.001 (0.978–4.094) 0.058 2.453 (1.040–5.786) 0.040
Composite (cardiac mortality and/or HF) 4 (11.1%) 22 (29.7%) 3.213 (1.101–9.373) 0.033 4.108 (1.163–14.508) 0.028

CI, confidence interval; HF, heart failure; HR, hazard ratio; RVPB, right ventricular pacing burden.